FUJIFILM Medical Systems offers biomarkers AFP-L3 (lectin-reactive alpha-fetoprotein) and DCP (des-gamma-carboxy prothrombin, also-known-as PIVKA-II), intended to aid in risk assessment of patients with chronic liver disease for development of HCC in conjunction with other laboratory findings, imaging studies and clinical assessment. The use of AFP-L3 and DCP tests can aid in the early identification of patients with risk of developing HCC. They are CMS reimbursed and available at major reference laboratories.
Amador Alejo, email@example.com, 951-219-3084
Jeff Winick, firstname.lastname@example.org, 339-216-8131
Cindy Mays, email@example.com, 408-345-1638
George Rogge, firstname.lastname@example.org, 650-793-5321